Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dexmedetomidine Versus Midazolam for Continuous Sedation in the Intensive Care Unit (ICU) (MIDEX)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Orion Corporation, Orion Pharma
ClinicalTrials.gov Identifier:
NCT00481312
First received: May 31, 2007
Last updated: May 4, 2012
Last verified: November 2009